Skandinaviska Enskilda Banken (SEB)
AGN

Skandinaviska Enskilda Banken (SEB)’s Allergan plc AGN Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-53,705
Closed -$7.18M – 789
2018
Q4 		$7.18M Sell
53,705
-2,820
-5% -$462K 0.06% 213
2018
Q3 		$10.8M Buy
+56,525
New +$10.4M 0.08% 182

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s AGN Position: Q1 2019 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 53,705 shares — an estimated $7.18M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in AGN in Q3 2018 and held it in 2 quarters. The position peaked at $10.8M in Q3 2018. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 53,705 Allergan plc shares in Q1 2019, an estimated $7.18M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Allergan plc in Q3 2018 and held it in 2 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Allergan plc position peaked at $10.8M in Q3 2018.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2019, filed 15 May 2019.